Cell Growth & Differentiation, Vol 8, Issue 4 417-423, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a

DJ Olson, DM Gibo, G Saggers, W Debinski and R Kumar
Department of Surgery, College of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033, USA.

Wnt gene family members are thought to play an important role in cell growth and differentiation. When normal wnt gene expression is disrupted, there is the potential for cell transformation. We have found previously that a strong correlation exists between the loss of normal wnt-5a gene expression and cell transformation (Olson and Papkoff, Cell Growth & Differ., 5: 197-206, 1994). Recently, this has been tested directly using antisense wnt-5a, which, when expressed in mouse mammary cells, results in cell transformation (Olson and Gibo, Antisense wnt-5a transforms C57MG mouse mammary epithelial cells, manuscript in preparation). We hypothesize that wnt-5a is a growth-regulating gene, the disruption of which could result in tumorigenesis. The multistage progression of many human cancers involves the loss of normal tumor suppressor gene(s) activity. Several tumor suppressor genes are thought to map to chromosome 3p11-p25. We have studied the ectopic expression of human wnt-5a (3p14-p21) in a tumorigenic uroepithelial cell line with deletion of chromosome 3p13-p21.2. This results in loss of tumorigenicity in athymic nude mice and suppresses anchorage-independent cell growth in soft agar. This suggests that human wnt-5a is a novel tumor suppressor gene in uroepithelial cell carcinoma and may be one of the suppressor genes deleted or rearranged on chromosome 3p.

This article has been cited by other articles:

				J. Ying, H. Li, J. Yu, K. M. Ng, F. F. Poon, S. C. C. Wong, A. T.C. Chan, J. J.Y. Sung, and Q. Tao WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer Clin. Cancer Res., January 1, 2008; 14(1): 55 - 61. [Abstract] [Full Text] [PDF]

				S Ripka, A Konig, M Buchholz, M Wagner, B Sipos, G Kloppel, J Downward, T. Gress, and P Michl WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer Carcinogenesis, June 1, 2007; 28(6): 1178 - 1187. [Abstract] [Full Text] [PDF]

				I. M. Bachmann, O. Straume, H. E. Puntervoll, M. B. Kalvenes, and L. A. Akslen Importance of P-Cadherin, {beta}-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma Clin. Cancer Res., December 15, 2005; 11(24): 8606 - 8614. [Abstract] [Full Text] [PDF]

				M. Jonsson, J. Dejmek, P.-O. Bendahl, and T. Andersson Loss of Wnt-5a Protein Is Associated with Early Relapse in Invasive Ductal Breast Carcinomas Cancer Res., January 1, 2002; 62(2): 409 - 416. [Abstract] [Full Text] [PDF]

				K. Julicher, G. Marquitan, N. Werner, W. Bardenheuer, L. Vieten, F. Brocker, H. Topal, S. Seeber, B. Opalka, and J. Schutte Novel Tumor Suppressor Locus in Human Chromosome Region 3p14.2 J Natl Cancer Inst, September 15, 1999; 91(18): 1563 - 1568. [Abstract] [Full Text] [PDF]

				M. Mandal and R. Kumar Bcl-2 Modulates Telomerase Activity J. Biol. Chem., May 30, 1997; 272(22): 14183 - 14187. [Abstract] [Full Text] [PDF]